Locations:
Search IconSearch

Tag: tricuspid regurgitation (TR)

illustration of tricuspid valve regurgitation

TRILUMINATE Health Status Analysis: T-TEER Patients Likelier to Be ‘Alive and Well’ at 1 Year

Investigators conclude that improved self-reports go beyond possible placebo effect for severe TR

23-HVI-3606664 CQD 650×450 (1)

TRILUMINATE Pivotal Trial: What Are Its Implications for Tricuspid Regurgitation Care?

TEER is found to be a safe and good option for severe TR in select patients

22-HVI-3135510 CQD 650×450

A Closer Look at Tricuspid Regurgitation in Pulmonary Arterial Hypertension

New study illuminates mechanical underpinnings of secondary leaks

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-HVI-2843464_transcatheter-bicaval-valves-system_650x450

First Transcatheter TricValve System Implanted for Tricuspid Regurgitation in North America

FDA-designated breakthrough device offers first treatment option for severe TR and right HF

22-HVI-2623151 CQD 650×450

Large Cohort Study of Isolated Tricuspid Regurgitation Yields Novel Risk Score to Guide Care

Companion study shows apparent benefit from surgery in both primary and secondary TR

BackPage 1 of 1Next

Advertisement

Ad